vimarsana.com

Latest Breaking News On - Stonepine capital management - Page 7 : vimarsana.com

Alimera Sciences (NASDAQ:ALIM) Upgraded to Buy at StockNews com

Alimera Sciences (NASDAQ:ALIM – Get Free Report) was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating in a report issued on Monday. Separately, Maxim Group initiated coverage on shares of Alimera Sciences in a research report on Monday, March 25th. They set a “buy” rating and a $10.00 price target […]

Alimera Sciences (NASDAQ:ALIM) Stock Rating Upgraded by StockNews com

Alimera Sciences (NASDAQ:ALIM – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Monday. Separately, Maxim Group initiated coverage on shares of Alimera Sciences in a report on Monday, March 25th. They set a “buy” rating and a $10.00 […]

Evolus, Inc (NASDAQ:EOLS) is favoured by institutional owners who hold 57% of the company

Key Insights Given the large stake in the stock by institutions, Evolus' stock price might be vulnerable to their.

Surrozen (SRZN) Announces $192 5M Private Placement

Surrozen (SRZN) Announces $192 5M Private Placement
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Galapagos (NASDAQ:GLPG) Stock Rating Reaffirmed by Bank of America

Bank of America reiterated their underperform rating on shares of Galapagos (NASDAQ:GLPG – Free Report) in a report released on Thursday, MarketBeat.com reports. The brokerage currently has a $31.00 price target on the biotechnology company’s stock, down from their prior price target of $41.00. Several other equities research analysts have also recently weighed in on […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.